Safe and Secure Medicine Supply for Hardworking Americans Act of 2020

This bill bans in certain instances the importation of drugs and medical devices from a foreign manufacturing facility that has been subject to a recall, imposes additional duties on imported drugs, and contains other related provisions.

The Food and Drug Administration shall ban drug or device imports from a foreign facility for a specified amount of time if a drug or device from that facility has been subject to a Class I or Class II recall. The bill imposes civil monetary fines for any individual or entity that violates such an import ban.

The bill also imposes, on top of any other duties, a 25% duty on drugs imported from China, a 20% duty on drugs imported from India, and a 10% duty on drugs imported from any other country.

The duties and fines established under this bill shall go into a fund for supporting and incentivizing new pharmaceutical or medical device manufacturing in the United States.

The bill also requires each drug sold to state on its label the country of origin of each active pharmaceutical ingredient.